The newly issued U.S. Patent No. 10,755,138 covers the application of point-wise mutual information maps to quantify spatial intratumor heterogeneity and identify diagnostic regions of interest in tissue samples. This patent has been exclusively licensed to SpIntellx, Inc. from the University of Pittsburgh and further adds to the strong and growing IP portfolio of SpIntellx around spatial analytics, xAI and spatial network biology.
SpIntellx at AACR 2022
SpIntellx is ushering a new era of unbiased spatial analytics and explainable AI in precision pathology at AACR 2022 SpIntellx announces that it will attend